Tata Motors share price records sharpest single-day surge in 6 months after CFO’s optimistic outlook on JLR

Shares of Tata Motors Ltd. registered a significant jump of 3.6% on Wednesday, March 12, hitting an intraday high of ₹671.90 on the NSE. This sharp rise came after the company’s Chief Financial Officer (CFO) held an analyst meet on Tuesday, where he provided a reassuring outlook on the company’s future trajectory. The surge also helped the stock snap a 2-day losing streak.

Biggest single-day gain in 6 months

Tata Motors’ stock posted its highest single-day move in 6 months, reflecting renewed investor confidence. The bullish sentiment followed the CFO’s assurance that Jaguar Land Rover (JLR) would meet its fourth-quarter EBIT margin guidance of 10% and that the company is on track to become net debt-free by the end of the financial year.

Key takeaways from the CFO’s commentary

The CFO’s discussion highlighted several positive developments for Tata Motors:

  • Jaguar Land Rover’s strong financial outlook: The CFO reaffirmed that JLR remains on track to meet its quarterly targets, contributing to overall stability.
  • Positive momentum in key markets: The US market continues to perform well, while Tata Motors is witnessing strong growth in China through JLR.
  • European demand less challenging than expected: The European Union market conditions are improving, and the UK market is showing signs of recovery.
  • Premiumisation strategy in progress: While the premiumisation of JLR and the Commercial Vehicles (CV) business in India is advancing well, the Passenger Vehicle (PV) segment requires further improvement.
  • Domestic CV margin improvement on track: Tata Motors is successfully executing its strategy to enhance margins in the domestic commercial vehicle segment.
  • Market share focus in the small CV segment: The company aims to strengthen its position in the small commercial vehicle category.

Tata Motors among top gainers on Nifty 50

Tata Motors emerged as one of the top-performing stocks on the Nifty 50 index on Wednesday. The stock’s 3.6% rally to ₹671.90 places it 10.82% above its 52-week low of ₹606.30, indicating strong investor confidence and renewed buying interest.

Conclusion

With positive guidance from the management and steady progress across key business verticals, Tata Motors remains a key stock to watch in the evolving automotive landscape.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Retirement Planning: How a One-Time Investment of ₹5 Lakh May Generate ₹1 Lakh Monthly Income

As individuals enter retirement, they often face reduced or no active income sources. However, expenses such as healthcare, daily living costs, and leisure activities continue to exist. A well-planned retirement corpus ensures financial independence and provides a stable income stream.

One approach to achieving this is by leveraging a combination of a one-time investment and a systematic withdrawal plan (SWP), allowing for regular income withdrawals without depleting the entire corpus prematurely.

How Much Retirement Corpus Is Required?

With inflation steadily rising, the retirement corpus should be substantial enough to last a lifetime. It is crucial to estimate the amount needed based on future expenses, expected longevity, and potential medical emergencies. Planning early can help create a corpus large enough to provide sustainable withdrawals.

From ₹5 Lakh Investment to ₹1 Monthly Income

To illustrate the potential of a long-term investment, let us divide the calculation into 2 phases:

  1. Phase 1: Growing the corpus from a one-time investment over 15 years.
  2. Phase 2: Withdrawing a regular monthly income through an SWP.

Phase 1: Growth of ₹5 Lakh Over 15 Years

If an individual invests ₹5 lakh in a long-term investment avenue, assuming a 12% annualised return, the estimated corpus after 15 years would be:

  • Invested Amount: ₹5,00,000
  • Estimated Returns: ₹1,44,79,961
  • Total Corpus After 15 Years: ₹1,49,79,961

Phase 2: Taxation on Corpus

As this investment qualifies as a long-term capital gain (LTCG), taxation rules apply:

  • LTCG exemption: ₹1,25,000
  • Tax rate: 12.50% 
  • Estimated tax liability: ₹18,56,870
  • Post-tax corpus: ₹1,29,98,091

How to Draw ₹1 Lakh Monthly Income for 15 Years

Once the corpus is built, the investor may place it in a mutual fund scheme offering approximately 10% returns annually. By initiating an SWP, a structured withdrawal of ₹1 lakh per month can be maintained for 15 years.

Final Estimates

  • Total withdrawn over 15 years: ₹1.80 crore
  • Remaining balance after 15 years: ₹1.61 crore
  • Total earnings from the investment: ₹2.11 crore

Conclusion

Retirement planning is crucial for financial security, and a well-strategised one-time investment can create a sustainable income stream. By allowing sufficient time for growth and utilising an SWP, a single investment of ₹5 lakh may potentially provide ₹1 lakh per month for 15 years, ensuring a comfortable retirement.

This informational approach highlights the significance of early investing, compounding, and structured withdrawals to create long-term financial stability.

Curious about your SBI SIP returns? Get accurate estimates of your investment growth using our SBI SIP Calculator and stay ahead of your financial goals.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Carysil Secures US Supply Agreement and Expands Global Presence

Carysil, a leading manufacturer of kitchenware and appliances, has made strategic moves to strengthen its global presence. The company recently secured a major supply agreement in the United States and expanded its ownership in a UK-based subsidiary. These developments reflect Carysil’s commitment to growth and international expansion.

Carysil’s Major Supply Agreement in the US

On March 12, Carysil’s stock rose over 5% following the announcement of an agreement with US-based Karran Inc. The deal aims to meet the rising demand for Quartz kitchen sinks from a major American home retail chain. As per the agreement, Carysil will commit to producing a minimum of 150,000 Quartz kitchen sinks annually, starting from May 2025.

To support the increased production, the company will invest approximately $510,000 in upgrading its manufacturing infrastructure. This includes acquiring new moulds, machinery, and utilities to ensure a seamless supply to the US market.

Full Acquisition of Carysil Brassware in the UK

In addition to its US expansion, Carysil has strengthened its European footprint. In August, its wholly-owned subsidiary, Carysil UK Ltd, announced the acquisition of the remaining 30% stake in Carysil Brassware Ltd (formerly The Tap Factory Ltd). This £350,000 acquisition makes Carysil Brassware a fully owned subsidiary.

Initially, Carysil UK acquired a 70% stake in April 2023 for £1.16 million, based on an enterprise value of £1.65 million. The agreement allowed the purchase of the remaining 30% stake between April and July 2026, based on a 6x EBITDA valuation. By finalising the acquisition ahead of schedule, Carysil aims to consolidate its presence in the UK market.

Carysil Share Performance

As of March 11, 2025, at 11:58 AM, the Carysil share price is trading at ₹529.00 per share, up by 4.76% from the previous closing price. The stock has declined by over 13% over the last month.

Conclusion

Carysil’s recent strategic moves highlight its focus on international expansion and market leadership. With a significant US supply deal and a completed UK acquisition, the company is well-positioned for growth in key global markets.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Crizac Ltd Secures SEBI Approval for ₹1,000 Crore IPO

Crizac Ltd., a Kolkata-based business-to-business education platform, has obtained the Securities and Exchange Board of India’s (SEBI) final approval to proceed with its initial public offering (IPO). The company, which specialises in international student recruitment, aims to offer its shares exclusively through an offer for sale (OFS) amounting to ₹1,000 crore. This move will enable its promoters to divest equity stakes while allowing investors to participate in its growth.

Details of the IPO and Offer for Sale

The IPO, which follows the refiling of draft papers with SEBI on 18 November 2024, consists solely of an offer for sale by the company’s promoters. The OFS includes equity shares worth ₹ 841 crore from Pinky Agarwal and ₹ 159 crore from Manish Agarwal, with a face value of ₹ 2 per share. A portion of the offer has been reserved for eligible employees.

As the issue is entirely an OFS, Crizac Ltd. will not receive any proceeds from the sale. The selling shareholders will gain from the offer after deducting applicable taxes and related expenses. The company’s shares are set to be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Equirus Capital Pvt. and Anand Rathi Advisors Ltd. are the book-running lead managers for the issue, while Link Intime India Pvt. is the registrar.

Crizac Ltd.’s Market Presence and Operations

Crizac Ltd. plays a vital role in the international education sector by connecting global institutions with student recruitment agents. The company provides services to institutions across the UK, Canada, Ireland, Australia, and New Zealand.

 

During the six months ending 30 September 2023, as well as in the past three financial years, Crizac facilitated student enrolment applications from over 75 countries through its registered agents. The company has processed more than 5.95 lakh student applications and partnered with over 135 global universities. By 30 September 2024, Crizac had over 7,900 registered agents globally, with 2,532 active agents in fiscal year 2024. Its operations extend across key markets such as India, the UK, Nigeria, Pakistan, Bangladesh, Nepal, Sri Lanka, Kenya, Vietnam, Canada, and Egypt.

Apart from its strong presence in India, Crizac Ltd. has co-primary operations in London and employs consultants in various countries, including Cameroon, China, Ghana, and Kenya. This international reach strengthens its position as a leading player in the student recruitment sector.

Conclusion

With SEBI’s final observation in place, Crizac Ltd. is set to launch its ₹1,000 crore IPO, marking a significant milestone in its journey. The company’s extensive global presence and expertise in student recruitment position it as a key player in the international education industry.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Bajaj Allianz Life Introduces Focused 25 Fund

Bajaj Allianz Life Insurance has launched the Focused 25 Fund, a unit-linked insurance plan (ULIP) fund that aims to provide long-term capital appreciation. The fund follows a concentrated investment approach, holding up to 25 stocks across market capitalizations, with a primary focus on large-cap companies. The New Fund Offer (NFO) is open until March 20, 2025, and will be available through Bajaj Allianz Life’s ULIP products.

Investment Strategy

The Focused 25 Fund follows a high-conviction strategy, investing in companies with strong fundamentals, sustainable growth potential, and corporate governance standards. It is sector-agnostic, meaning it does not limit investments to specific industries but instead diversifies based on market conditions. The fund actively manages investments while maintaining a concentrated portfolio.

Benchmark and Risk Profile

The fund is benchmarked against the Nifty 100 Index, which tracks the performance of India’s largest companies by market capitalization. This allows investors to assess the fund’s performance relative to a broad set of top-listed firms. The fund is intended for investors with a higher risk tolerance due to its concentrated nature.

About Bajaj Allianz Life

Bajaj Allianz Life Insurance is a joint venture between Bajaj Finserv and Allianz SE. The company manages assets worth over ₹1.20 lakh crore and has an individual claim settlement ratio of 99.23% as of January 31, 2025. 

Conclusion

The Focused 25 Fund is available only through Bajaj Allianz Life’s ULIP products. The NFO will close on March 20, 2025, after which the fund will continue as part of the company’s investment offerings. Investors seeking a concentrated stock portfolio within a ULIP framework can access this fund through the company’s existing policies.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Zydus Acquires Majority Stake in Amplitude Surgical for €256.8 Mn

Zydus Lifesciences has announced the acquisition of an 85.6% stake in France-based Amplitude Surgical SA for €256.8 million. The deal will be followed by a mandatory cash tender offer for the remaining shares at the same purchase price of €6.25 per share. If completed, the full acquisition would be valued at €300 million, leading to Amplitude’s delisting from Euronext Paris.

At 10:11 AM on March 12, 2025, Zydus Lifesciences Ltd share traded a 2.32% down at ₹879.50, down 3.48% over the past month and 8.73% over the past year.

Acquisition Price and Premiums

The acquisition price represents an 80.6% premium over Amplitude Surgical’s last closing price on March 10, 2025. It also shows premiums of 88.2% and 92.2% over the three-month and six-month volume-weighted average prices, respectively. The transaction is subject to regulatory approvals, including clearance from France’s Economy Ministry, and is expected to close in the first half of 2025.

Amplitude Surgical’s Financials

Amplitude Surgical specializes in lower-limb orthopaedic implants, including knee and hip prostheses. For FY24, the company reported sales of €106 million and an EBITDA of €27.1 million. In the six months ending December 31, 2024, it generated €51.5 million in sales, reflecting a 5% year-on-year growth. The company has operations in France, Brazil, Australia, Germany, Switzerland, Belgium, and South Africa.

Zydus Lifesciences’ Performance

Zydus Lifesciences recorded a revenue of ₹19,547 crore in FY24. For the first nine months of FY25, the company reported a 19% year-on-year revenue growth to ₹16,713.6 crore, an EBITDA of ₹4,933 crore (up 31%), and a net profit of ₹3,354.6 crore (up 25%). The acquisition will be funded through a combination of debt and internal accruals.

Conclusion

Currently, Amplitude Surgical does not operate in India. The Indian orthopaedic limb implants market was valued at $791.4 million in 2023 and is projected to reach $1,256.3 million by 2030, as per the reports. Zydus may introduce Amplitude’s products in the Indian market. Apart from orthopaedics, Zydus is also involved in nephrology and interventional cardiology through its medical devices division, Zydus MedTech.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Kotak Nifty Top 10 Equal Weight Index Fund Draft Filed

Kotak Mahindra Mutual Fund has filed a draft for the Kotak Nifty Top 10 Equal Weight Index Fund, an open-ended index scheme that aims to replicate the Nifty Top 10 Equal Weight Index. The fund will invest in 10 stocks selected from the Nifty 50, ensuring equal allocation among them.

Investment Strategy

The fund seeks to provide returns that correspond to the total returns of the underlying index, subject to tracking error. It will follow a passive investment strategy, investing in the same stocks and weightage as the Nifty Top 10 Equal Weight Index. The portfolio will be rebalanced quarterly based on changes in the index composition​.

The scheme will be managed by Devender Singhal and Satish Dondapati, with Abhishek Bisen handling the debt securities allocation​.

Benchmark and Risk Factors

The scheme will be benchmarked against the Nifty Top 10 Equal Weight Index (Total Return Index – TRI). Risks include tracking errors, market volatility, and potential liquidity concerns, particularly during rebalancing periods​.

Fund Composition

Nifty Top 10 Equal Weight Index aims to track the performance of the top 10  stocks selected based on 6-month average free-float market capitalisation from the Nifty 50. Some of them are

Liquidity and Investment Details

The fund will be available for subscription and redemption on all business days at NAV-based prices. Units will be issued at ₹10 per unit during the New Fund Offer (NFO). The minimum investment required is ₹100, with subsequent investments allowed in multiples of ₹100​.

Conclusion 

The fund will have no exit load. The Total Expense Ratio (TER) is capped at 1%, as per SEBI regulations​. This filing is currently under review, and details are subject to regulatory approvals.

Ready to watch your savings grow? Try our SIP Calculator today and unlock the potential of disciplined investing. Perfect for planning your financial future. Start now!

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Waaree Renewable Technologies Gets ₹740 Crore Contract for Solar Power Project

Waaree Renewable Technologies Ltd (WRTL) has received a Letter of Award (LOA) worth ₹740.06 crore for Engineering, Procurement, and Construction (EPC) work on a 125 MWAC (181.3 MWp DC) solar power project. The order, awarded by a major power distribution company(name undisclosed), includes turnkey execution along with operation and maintenance services.

As of March 12, 2025, at 10:14 AM, Waaree Renewables Technologies Ltd Shares traded a 1.50% up at ₹814.90.

Project Details

The project will be executed by a three-member consortium, with Waaree Renewable Technologies as one of the members. The intra-se arrangement between the consortium partners is yet to be finalised. The project is scheduled for completion within 18 months from the date of contract signing.

“we are pleased to inform you that a consortium of three members comprising our Company WAAREERTL as one of the members has received a Letter of Award (LOA) for Engineering, Procurement and Construction (EPC) works for solar power project of 125 MWAC (181.3 MWp DC) capacity on turnkey basis along with Operation and Maintenance,” according to filings.

Financial Performance

In Q3 FY25, the company reported a 16.71% decline in net profit, standing at ₹53.51 crore, compared to ₹64.25 crore in Q3 FY24. However, revenue from operations increased by 11.15% year-on-year, reaching ₹360.35 crore for the quarter ending December 31, 2024.

Previous Orders

Last year, Waaree Renewable Technologies received a term sheet for an EPC contract involving a 2012.47 MWp DC ground-mounted solar PV project. The estimated order value was ₹1233.47 crore (excluding taxes). The timeline for completion was to be determined in mutual agreement with the involved parties.

Conclusion

The awarded contract is classified as a commercial order and does not fall under related-party transactions. The project is being developed for a domestic entity in India’s power sector.

Waaree Renewable Technologies is a subsidiary of Waaree Group, which operates in the solar energy sector. The company provides EPC services and develops, finances, and operates solar power projects, catering primarily to commercial and industrial customers.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

CG Power Secures ₹450 Crore Railway Order For Vande Bharat Parts

CG Power and Industrial Solutions Ltd (CG) has signed a long-term supply agreement with Kinet Railway Solutions Limited for the supply and servicing of railway components. The agreement includes propulsion kits, motors, transformers, and other railway products.

As part of this agreement, CG has secured a purchase order worth ₹400-450 crore to supply railway components for 10 Vande Bharat trainsets. Additionally, the contract includes a 35-year service order for continued maintenance and support.

Background and Railway Operations

CG Power has been operating for over 86 years and has a presence in the railway industry through its traction machines, propulsion systems, and railway signalling products. The company has also expanded into the Train Collision Avoidance System (TCAS), known as KAVACH, which focuses on railway safety technology.

Manufacturing Presence

Headquartered in Mumbai, CG Power operates 18 manufacturing plants across India and Sweden. It manufactures a range of traction motors, propulsion systems, and signalling relays for Indian Railways, along with induction motors, drives, transformers, and switchgear for industrial applications. The company has also expanded into consumer appliances, producing fans, pumps, and water heaters, as per their filing.

Financials 

CG Power reported revenues of ₹8,046 crore (USD 964 million) in FY24. The company has approximately 3,113 employees. Since November 2020, CG Power has been a part of the Murugappa Group, which operates businesses across agriculture, engineering, and financial services, with total group revenues of ₹74,200 crore.

At 10:46 AM March 12, 2025, CG Power and Industrial Solutions Ltd share traded a 0.13% up at ₹608.95.

Conclusion

This railway contract further expands CG Power’s role in the railway sector. The 35-year service agreement will help with continued business operations in railway electrification and modernization.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

PB Fintech to Invest ₹696 Crore in Subsidiary PB Healthcare Services

PB Fintech Ltd, the parent company of Policybazaar, has announced its plan to invest up to ₹696 crore in PB Healthcare Services Private Limited, its wholly owned subsidiary. This investment, which will be executed through the purchase or subscription of equity shares and compulsory convertible preference shares (CCPS), is expected to take place during the financial year 2025-26. The move is aimed at strengthening PB Healthcare’s operations and accelerating its expansion in the healthcare and allied services sector.

Investment Structure and Shareholder Approval

PB Fintech’s investment in PB Healthcare Services is subject to approval from its shareholders via a postal ballot. The funding will be made alongside contributions from external investors, including Chairman & CEO Yashish Dahiya, Executive Vice Chairman Alok Bansal, and three Key Managerial Personnel (KMPs).

Following the transaction, PB Fintech will hold up to 33.63% of PB Healthcare’s equity on a fully diluted basis. Since the acquisition is classified as a related party transaction, it will be executed at a fair valuation determined by a Registered Valuer.

Strategic Objectives and Business Expansion

PB Healthcare Services was incorporated in January 2025 and operates within the healthcare and allied services industry. The fresh capital infusion aims to cover operational expenses, enhance brand visibility, and fund strategic initiatives to strengthen the subsidiary’s market presence.

With this investment, PB Fintech is positioning itself to play a significant role in the evolving healthcare landscape. The company seeks to leverage its expertise and financial resources to drive sustainable growth and innovation within its subsidiary.

PB Fintech Share Performance

As of March 11, 2025, at 10:32 AM, the shares of PB Fintech are trading at ₹1,397.40 per share, down by 4.78% from the previous closing price.

Conclusion

PB Fintech’s decision to invest ₹696 crore in PB Healthcare Services highlights its commitment to expanding into the healthcare sector. With shareholder backing and participation from key executives, this investment is expected to enhance operational capabilities, increase market competitiveness, and support long-term business growth.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.